Some Chinese herbal medicine prices fluctuate or even soar, who is behind the push?

[pharmaceutical network market analysis] cardamom, natural bezoar, imported coix seed.. These varieties of traditional Chinese medicine have recently seen price increases, which have caused multimedia reports and industry attention, and also brought cost pressure to downstream traditional Chinese medicine manufacturers In the long run, some drugs will affect consumers So who is behind the price rise of Chinese herbal medicines? Recently, the price of some traditional Chinese medicine varieties has risen Some traditional Chinese medicine varieties in the market have received news of price fluctuation or even skyrocketing For example, at the end of 2018, the price of cardamom, which was only about 55 yuan, has been rising continuously since August this year, breaking the 100 yuan mark in November, with an increase of more than 200%; the price of natural bezoar, which was about 100000 yuan in 2016, has risen to nearly 500000 yuan / kg today; the price of Coix, which was only 8.5 yuan at the end of last year, has risen to 16.5 yuan, with an increase of more than 94% According to CCTV, since November, many varieties in Chengdu lotus pond Chinese herbal medicine market have increased in varying degrees, with the increase varying from 10% to 50%; in Anguo Chinese herbal medicine market in Hebei Province, some varieties with large amount of consumption also started to increase their prices a month ago, with the increase range of 20% to 40%, and some varieties even doubled their prices Behind the rising price of traditional Chinese medicine, the downstream production enterprises are also in a more "embarrassing" situation According to the industry, the price increase of traditional Chinese medicine will directly affect the price of traditional Chinese medicine, and consumers will eventually pay for some drugs Who is the pusher behind? So why does the price of traditional Chinese medicine rise? Market supply and demand imbalance, artificial malicious "speculation", industry situation.. Who is the driving force behind it? The author learned from the insiders that the price rise of traditional Chinese medicine is actually the result of comprehensive factors The gap between supply and demand has increased Take the natural bezoar, which is comparable to the traditional Chinese medicine "gold", for example As a medicinal raw material, bezoar is an important raw material for many Chinese patent medicines "This kind of medicine itself is in short supply With the expansion of market demand, the natural bezoar in the market has an obvious upward trend under the condition of short supply." Industry insiders predict that if the price of bezoar continues to rise in the future, downstream manufacturers of qinghuojiedu (bezoar detoxification, bezoar Shangqing, etc.), xingnaokaiqiao (Angong Niuhuang Pill, etc.) and cold medicine varieties may adjust the factory price In addition, due to the weather, some Chinese herbal medicines will reduce their production, and there will also be a gap between supply and demand, resulting in price increases Human factors Some Chinese medicine suppliers will stock up first and then sell at a high price For example, cardamom, as a non essential spice, has less goods due to the impact of production reduction, and is easy to be artificially hyped due to strict customs clearance, import difficulty and small market volume The industry said that in the long run, speculation will only "lift a stone and hit your own feet." Industry situation For example, since December 1 this year, China's newly revised Drug Management Law has been implemented, and downstream manufacturers have also improved their requirements for the quality of traditional Chinese medicine In the market of traditional Chinese medicine, those varieties with high quality and stable content of ingredients become the target of the enterprise, while in the case of more monks and less porridge, the price may rise In addition, the industry is also worried that after the introduction of Pharmacopoeia 2020, the quality requirements of traditional Chinese medicine varieties will be more stringent, and the varieties with high quality standards may also increase prices Behind the rising price of traditional Chinese medicine, the cost control pressure of traditional Chinese medicine enterprises will also increase According to media reports, a traditional Chinese medicine company said that the price increase of domestic wild Sagittaria in the near future would probably lead to the price increase of a company's formula particles Sagittaria is the raw material of some traditional Chinese medicine granules "Even if we stock up, there will be a day when we run out, and we will be forced to raise the price."